Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.

P. Haldar,C. Brightling,A. Singapuri,B. Hargadon,S. Gupta,W. Monteiro,P. Bradding,R. Green,A. Wardlaw,H. Ortega,I. Pavord
DOI: https://doi.org/10.1016/j.jaci.2013.11.026
IF: 14.29
2014-03-01
Journal of Allergy and Clinical Immunology
Abstract:
What problem does this paper attempt to address?